FunPep Co 4881.T · JPY

Its shares trade on Tokyo Stock Exchange under the ticker 4881.T. It has been listed since 25 December 2020. In the fiscal year to 31 December 2025, it reported revenue of ¥314,000 and a net loss of ¥1.91bn. At that date it held total assets of ¥1.98bn and shareholders' equity of ¥1.46bn.

FunPep KK engages in the research and development of pharmaceutical drugs, functional cosmetics and medical devices. The company is headquartered in Chuo-Ku, Tokyo-To. The company went IPO on 2020-12-25. The main business is to promote research and development of functional peptides, which are the results of research at the Graduate School of Medicine, Osaka University, and to put them into practical use in the business fields such as pharmaceuticals, cosmetics and medical devices. The business model defines its technical area as a functional peptide-based area and a related area that has synergies with it. The Research & Development pipeline is composed of research themes for antibody-inducing peptides and developed products. The firm is engaged in the sale of peptide active ingredients through cosmetic raw material trading companies or sales companies.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Toshimi MiyoshiPresident, Chief Executive Officer, Representative Director, since 2015
• Mr. Taketoshi HayashiChief Financial Officer, Director of Administration, Director, since 2015
• Mr. Hideki TomiokaDirector of Research and Development, CSO, Director, since 2015
• Mr. Norikazu EikiIndependent Director
• Mr. Makoto HaraIndependent Director
• Mr. Hiroshi KubotaIndependent Director
• Mr. Tsutomu UneIndependent Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.